Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

1.

Beta-blockers for primary prevention in hypertension: era bygone?

Panjrath GS, Messerli FH.

Prog Cardiovasc Dis. 2006 Sep-Oct;49(2):76-87. Review.

PMID:
17046433
[PubMed - indexed for MEDLINE]
2.

Cardiovascular protection using beta-blockers: a critical review of the evidence.

Bangalore S, Messerli FH, Kostis JB, Pepine CJ.

J Am Coll Cardiol. 2007 Aug 14;50(7):563-72. Epub 2007 Jul 30. Review.

PMID:
17692739
[PubMed - indexed for MEDLINE]
Free Article
3.

Beta-blockers: no longer an option for uncomplicated hypertension.

Bangalore S, Kamalakkannan G, Messerli FH.

Curr Cardiol Rep. 2007 Nov;9(6):441-6. Review.

PMID:
17999868
[PubMed - indexed for MEDLINE]
4.

Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.

Epstein BJ, Anderson S.

Pharmacotherapy. 2007 Sep;27(9):1322-33.

PMID:
17723086
[PubMed - indexed for MEDLINE]
5.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
[PubMed - indexed for MEDLINE]
6.

Using fixed-dose combination therapies to achieve blood pressure goals.

Chrysant SG.

Clin Drug Investig. 2008;28(11):713-34. Review.

PMID:
18840014
[PubMed - indexed for MEDLINE]
7.

Beta-blockers in hypertension.

Ram CV.

Am J Cardiol. 2010 Dec 15;106(12):1819-25. doi: 10.1016/j.amjcard.2010.08.023. Epub 2010 Nov 2. Review.

PMID:
21126627
[PubMed - indexed for MEDLINE]
8.

Blood pressure guidelines - where are we now?

[No authors listed]

Drug Ther Bull. 2008 Sep;46(9):65-9. doi: 10.1136/dtb.2008.09.0020.

PMID:
18784380
[PubMed - indexed for MEDLINE]
9.

Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?

Dunne F, Kendall MJ, Martin U.

Drugs. 2001;61(4):429-35. Review.

PMID:
11324677
[PubMed - indexed for MEDLINE]
10.

Should beta-blockers still be used as initial antihypertensive agents in uncomplicated hypertension?

Wu A.

Ann Acad Med Singapore. 2007 Nov;36(11):962-4.

PMID:
18071610
[PubMed - indexed for MEDLINE]
Free Article
11.

The role of β-blockers in the management of hypertension: an Asian perspective.

Tomlinson B, Dalal JJ, Huang J, Low LP, Park CG, Rahman AR, Reyes EB, Soenarta AA, Heagerty A, Follath F.

Curr Med Res Opin. 2011 May;27(5):1021-33. doi: 10.1185/03007995.2011.562884. Epub 2011 Mar 16. Review.

PMID:
21410302
[PubMed - indexed for MEDLINE]
12.

Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?

Kountz DS.

Postgrad Med. 2009 Jan;121(1):14-24. doi: 10.3810/pgm.2009.01.1951. Review.

PMID:
19179810
[PubMed - indexed for MEDLINE]
13.

Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?

Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.

Blood Press. 2007;16(1):6-12.

PMID:
17453746
[PubMed - indexed for MEDLINE]
14.

How useful are beta-blockers in cardiovascular disease?

Bangalore S, Parkar S, Messerli FH.

Anadolu Kardiyol Derg. 2006 Dec;6(4):358-63. Review.

PMID:
17162285
[PubMed - indexed for MEDLINE]
Free Article
15.

Beta-blockers in hypertension.

Hansson L.

J Hypertens Suppl. 1987 Aug;5(3):S61-7. Review.

PMID:
2889813
[PubMed - indexed for MEDLINE]
16.

Current and future status of beta-blockers in the treatment of hypertension.

Chrysant SG, Chrysant GS, Dimas B.

Clin Cardiol. 2008 Jun;31(6):249-52. doi: 10.1002/clc.20249. Review.

PMID:
18543303
[PubMed - indexed for MEDLINE]
17.

[Beta-blockers and arterial hypertension. Evidence-based medicine or excessive perseverance?].

Verdecchia P, Angeli F, Achilli P, Castellani C, Repaci S, Ambrosio G.

G Ital Cardiol (Rome). 2007 Sep;8(9):552-8. Review. Italian.

PMID:
17972424
[PubMed - indexed for MEDLINE]
18.

[Clinical application of beta-blockers with particular reference to hypertension].

Kocijancić M.

Srp Arh Celok Lek. 1992 Jun;120 Suppl 4:10-6. Review. Serbian.

PMID:
18193806
[PubMed - indexed for MEDLINE]
19.

Evolving mechanisms of action of beta blockers: focus on nebivolol.

Mason RP, Giles TD, Sowers JR.

J Cardiovasc Pharmacol. 2009 Aug;54(2):123-8. doi: 10.1097/FJC.0b013e3181ad207b. Review.

PMID:
19528811
[PubMed - indexed for MEDLINE]
20.

Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.

Agabiti Rosei E, Rizzoni D.

Drugs. 2007;67(8):1097-107. Review.

PMID:
17521213
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk